ViaDerma, Inc.

ViaDerma, Inc.

VDRM - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$123.37K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
ViaDerma, Inc.ViaDerma, Inc.28.7-157%--13.5

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$123,371.00
Enterprise Value$577,197.00
Earnings per Share$0
Beta0.2
Outstanding Shares1,233,713,103

Return

Return on Equity157.44%ROE
Return on Assets-5.58%
Return on Invested Capital101.00%

Valuation & Multiples

P/E Ratio28.74P/E Ratio
PEG-3.17PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue0.96
Enterprise Value to EBIT-3.96
Enterprise Value to Net Income-3
Total Debt to Enterprise3.37
Debt to Equity-13.47Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About ViaDerma, Inc.

75 employees
CEO: Christopher A Otiko

ViaDerma, Inc., a specialty pharmaceutical enterprise based in the United States, focuses on both the development and commercialization of pharmaceutical products. It also licenses its proprietary technology to other companies within the...